文献速递乳腺US乳腺X线

使用新型超声图像处理技术表征乳腺微钙化

Characterization of Breast Microcalcifications Using a New Ultrasound Image-Processing Technique.
PubMed 文献 · J Ultrasound Med · 2018-11-13

研究纳入100例女性患者的104个乳腺微钙化病灶,以乳腺X线摄影为参考标准,评估MicroPure技术检测和表征微钙化的能力。MicroPure显示的微钙化平均数量为6.3±3.5个,而乳腺X线摄影为28.9±24.6个(P=.66)。MicroPure的恶性可疑度评分受试者工作特征曲线下面积为0.54~0.59,但恶性病例的微钙化数量显著多于良性病例(6.9±5.1 vs 5.3±3.7,P=.02)。结论认为MicroPure可识别微钙化区域但无法有效表征,可能作为引导活检的新方法。

要点

  • MicroPure可识别乳腺微钙化区域,但不能有效表征其良恶性。
  • MicroPure显示微钙化均数6.3±3.5个,乳腺X线摄影28.9±24.6个(P=.66)。
  • 恶性病例微钙化数量多于良性病例(6.9±5.1 vs 5.3±3.7,P=.02)。

核心结论

  • MicroPure能识别乳腺微钙化区域但不能有效表征,可能作为引导微钙化区域活检的新影像方法。

研究设计与样本

  • 前瞻性研究纳入100例女性患者的104个病灶,以乳腺X线摄影为参考标准,使用Aplio XG扫描仪宽带线阵探头行MicroPure检查;4名独立盲法读者(2名放射科医生和2名物理师)分析208个数字剪辑。

关键影像表现/征象

  • MicroPure将可疑钙化标记为蓝色叠加图像中的白点;MicroPure显示微钙化均数6.3±3.5个,乳腺X线摄影显示28.9±24.6个(P=.66)。

诊断标准与关键数值

  • MicroPure可疑度采用定性视觉模拟6分制(0=无发现,1=良性,至5=恶性);与病理结果比较的ROC曲线下面积为0.54~0.59;恶性病例微钙化均数6.9±5.1个 vs 良性病例5.3±3.7个(P=.02)。

临床应用与阅片要点

  • 作者认为MicroPure可识别乳腺微钙化区域但不能有效表征,可能作为引导微钙化区域活检的新影像方法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate a new commercial image-processing technique (MicroPure; Toshiba America Medical Systems, Tustin, CA) for detection and characterization of breast microcalcifications in patients undergoing stereotactic or ultrasound-guided biopsies using mammography as the reference standard.

METHODS: One hundred female patients, with a total of 104 lesions, scheduled for an image-guided biopsy of an area with breast microcalcifications (identified on a prior mammogram) underwent MicroPure examinations of the breast using an Aplio XG scanner (Toshiba America Medical Systems) with a broad-bandwidth linear array. MicroPure combines nonlinear imaging and speckle suppression to mark suspected calcifications as white spots in a blue overlay image. Four independent and blinded readers (2 radiologists and 2 physicists) analyzed 208 digital clips consisting of dual grayscale ultrasound and MicroPure imaging, counting the number of microcalcifications seen with MicroPure. The observers also assessed the level of suspicion on a qualitative, visual analog, 6-point scale from 0 (no findings) over 1 (benign) to 5 (malignant).

RESULTS: The mean number of microcalcifications ± SD seen was 6.3 ± 3.5, whereas mammography saw 28.9 ± 24.6 (P = .66). When the MicroPure level of suspicion scores were compared with pathologic results using a receiver operating characteristic curve analysis, the areas under the curve ranged from 0.54 to 0.59. Nonetheless, malignant cases were seen to have significantly more microcalcifications than benign cases (mean number of microcalcifications, 6.9 ± 5.1 versus 5.3 ± 3.7; P = .02).

CONCLUSIONS: MicroPure can be used to identify areas with breast microcalcifications but cannot effectively characterize such areas. Instead, MicroPure may represent a new imaging method for guiding a biopsy to areas of microcalcifications.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Machado P, Eisenbrey JR, Stanczak M, et al. Characterization of Breast Microcalcifications Using a New Ultrasound Image-Processing Technique. J Ultrasound Med. 2018. PMID: 30426546. doi:10.1002/jum.14861

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。